Skip to main content
Clinical Trials/NCT07010315
NCT07010315RecruitingNot Applicable

Development and Testing of a Patient-facing Educational Tool About Liver Cancer Prevention

M.D. Anderson Cancer Center1 site in 1 country40 target enrollmentStarted: May 1, 2025Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Enrollment
40
Locations
1
Primary Endpoint
Cognitive Testing

Study Overview

Brief Summary

To develop and test liver cancer prevention educational material.

Detailed Description

Primary Objectives:

  • To ensure the text for the site is understood by participants, participant comprehension will be measured qualitatively through cognitive testing. Adjustments will be made to the content, messages, and layout iteratively until interviewer notes show no large discrepancies between participant understanding and the meaning of the text.
  • To ensure the site is easy to use, usability will be measured qualitatively through usability testing. Adjustments will be made to the functionality of the patient-facing portions of the web-based tool iteratively until interviewer notes indicate that participants are able to input their risk factors and download the personal summary on their own.

Secondary Objectives:

  • To describe whether the site is acceptable to users, acceptability will be measured (as part of usability testing) with the Ottawa Acceptability Measures.
  • To describe participants' knowledge of liver cancer risk factors, knowledge will be measured (as part of usability testing) with Knowledge Questions developed for this study.

Study Design

Study Type
Observational
Observational Model
Ecologic Or Community
Time Perspective
Cross Sectional

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •At least 18 years old
  • •Participants at the HOPE Clinic
  • •Able to speak and read either English or Spanish
  • •For usability testing: Able to use and navigate websites on own smart phone or study computer

Exclusion Criteria

  • •Has been diagnosed with liver cancer
  • •Cannot provide consent or otherwise participate in research activities (e.g. vision or hearing impairment)

Arms & Interventions

Usability Testing (English and Spanish)

Participants will be asked to complete a pre-survey, navigate a liver cancer education website, provide their feedback and impressions, and complete a post- survey.

Intervention: Usability Testing (Behavioral)

Cognitive Interviews (English and Spanish)

Participants that agree to this part of the study will be asked to view patient education materials about liver cancer, complete a demographic survey, and do an interview one-on-one either online via Zoom, over the phone, or in person at HOPE Clinic.

Intervention: Cognitive Testing (Behavioral)

Outcomes

Primary Outcomes

Cognitive Testing

Time Frame: Up to 1.5 hours

Participant comprehension will be measured qualitatively through cognitive testing. In cognitive testing interviews, participants are asked to "think aloud" as they review and react to new information. Participants will be presented with the storyboard (mock-up) versions of the content and asked to describe in their own words what the information means to them. Cognitive interviews may include questions about content such as length, clarity of the language, and helpfulness of the educational material. A trained research team member will ask probing questions throughout interviews as needed. Based on patient feedback, modifications will be made iteratively to the content to ensure the content is understood and interpreted as intended. There is no post-survey for cognitive testing.

Usability Testing

Time Frame: Up to 1.5 hours

Usability will be measured qualitatively using a Usability Interview Guide. Usability will also be measured using the System Usability Scale. Acceptability will be measured with the Ottawa Acceptability Measures. Knowledge will be measured pre- and post- session using knowledge questions developed by the investigators and refined during cognitive testing.

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials